Bruce Wexler

Bruce Wexler is a partner in the Intellectual Property practice at Paul Hastings. Bruce is a trial lawyer with extensive experience litigating high-stakes patent cases in a range of technologies. He has represented clients as lead counsel in enforcement and defense matters involving multi-million- and multi-billion-dollar drug products.

He forms close partnerships with his clients to support successful outcomes, including in their bet-the-company cases. In Hatch-Waxman Act matters, he has opposed challenges by most generic drug companies. He has helped his clients with important drug products such as Aricept®, Pradaxa®, Mirapex®, Cyltezo®, Basaglar®, Entereg®, Emend® oral and Emend® for Injection, Aciphex®, Banzel®, Gocovri®, Comirnaty® and Opsumit®.

He is a former judicial law clerk of the U.S. Court of Appeals for the Federal Circuit, where he served under the Honorable Chief Judge Glenn L. Archer, Jr. He clerked for the Honorable Chief Judge Archer during the chief judge’s preparation of influential Federal Circuit decisions including Markman v. Westview.

Bruce is also an adjunct professor of law at New York University School of Law, where he teaches an advanced course in “Life Sciences and Patent Law.”